Overview

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

Status:
Completed

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

Investigation the Effects of Different Doses of SAMe in Subjects with Nonalcoholic Fatty Liver Disease and non-treated matched healthy volunteers as control group

Phase:

Phase 3

Details

Lead Sponsor:

Abbott

Collaborator:

PPD